Name | Title | Contact Details |
---|
About Kotak Mahindra Group: Established in 1985, the Kotak Mahindra Group is one of Indias leading financial services conglomerates. In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Groups flagship company, received a banking license from the Reserve Bank of India (RBI). With this, KMFL became the first non-banking finance company in India to become a bank – Kotak Mahindra Bank Limited. The consolidated balance sheet of Kotak Mahindra Group is over 1 lakh crore and the consolidated net worth of the Group stands at 13,943 crore (approx US$ 2.6 billion) as on September 30, 2012. The Group offers a wide range of financial services that encompass every sphere of life. From commercial banking, to stock broking, mutual funds, life insurance and investment banking, the Group caters to the diverse financial needs of individuals and the corporate sector. The Group has a wide distribution network through branches and franchisees across India, and international offices in London, New York, California, Dubai, Abu Dhabi, Bahrain, Mauritius and Singapore. For more information, please visit the companys website at http://www.kotak.com
A company dedicated to excellence in the insurance and financial services industries. Through data-driven management and lasting relationships, IH has built a solid foundation capable of taking companies to the next level of performance, profitability, and stability. Our business approach is straightforward. We believe that the power and success behind any business or industry lie within knowledge – knowledge of your products, the direction of your company, and the ongoing execution of a stellar strategic plan. These core assets, coupled with unmatched talent from a thriving corporate culture, are what we believe to be the key ingredients for achieving profitable, steady growth.
Berkley Program Specialists is a leading insurance operation dedicated exclusively to program business. We provide access to national admitted and non-admitted A+ XV insurance carriers, program management expertise, and reinsurance support when required to program administrators in the U.S. We are a casualty driven company, although we have the ability to offer ancillary property and automobile products as well. Our Mission Berkley Program Specialists goal is to be the preferred insurance operation for program administrators who are experts in the industries they serve and are looking for a stable, secure, and proven company to support and help grow their casualty-driven homogeneous niche program with annual GWP of at least $5 million. Business We Seek Our preferred client is a highly respected program administrator or insurance specialist who possesses the ability to quote, underwrite, rate, bind and issue policies within a homogeneous industry field. They should have a strong sense of integrity, significant expertise in their chosen industries, a differentiated value proposition, and a solid distribution system. Our preferred program opportunities consist of annual premiums in excess of $5 million, complete with strong, documented premium and loss histories.
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.